Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173268682> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W3173268682 abstract "The emergence of Type 2 Diabetes Mellitus (T2DM) as a clinical syndrome deviating from rudimentary models including “glucose-insulin” disparities to a clinical syndrome impinged upon hyperactivation of inflammatory-mediated signaling pathways, maladaptive pathophysiological changes, and pleiotropic sequelae has not only changed the nature of discussions regarding diabetes in academic circles, but also the treatment of T2DM clinically. The new challenges faced in preventing the advancement of T2DM coupled with the management of associated chronic disease states have impelled avenues for innovative treatments for T2DM sequelae while also ensuring glycemic control. For example, Sodium-Glucose Transport 2 inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA), in addition to passing mandated Food and Drug Administration (FDA) Cardiovascular Outcome Trials (CVOT), have displayed positive outcomes with respect to cardiorenal considerations in patients with T2DM. Such performances have recently elevated these pleiotropic medications to higher tiers of recommendations by medical societies such as the American Diabetes Association and the American College of Cardiology. Moreover, the tandem of the notion that pleiotropic pharmacotherapeutic options with an expanded understanding of T2DM on the epigenetic, molecular, and cellular domains have galvanized researchers to explore pharmacologic mechanisms in the context of our ever-changing model in T2DM. In this communication, we would like to use lessons from the “Effects of aspirin for primary prevention in persons with diabetes mellitus” (ASCEND) trial to implore aspiring researchers and practitioners to explore, or at least consider external factors of the T2DM patient populous when reporting findings of cardiovascular clinical endpoints for proper context." @default.
- W3173268682 created "2021-07-05" @default.
- W3173268682 creator A5014898451 @default.
- W3173268682 creator A5024808796 @default.
- W3173268682 creator A5033120729 @default.
- W3173268682 creator A5052312419 @default.
- W3173268682 creator A5083786375 @default.
- W3173268682 creator A5089823926 @default.
- W3173268682 date "2021-05-08" @default.
- W3173268682 modified "2023-10-16" @default.
- W3173268682 title "Raising the Bar When Assessing Cardiovascular Disease Outcome When Studies with Patients with Type 2 Diabetes Mellitus are Constructed: Revisiting ASCEND" @default.
- W3173268682 doi "https://doi.org/10.26420/austinjendocrinoldiabetes.2021.1083" @default.
- W3173268682 hasPublicationYear "2021" @default.
- W3173268682 type Work @default.
- W3173268682 sameAs 3173268682 @default.
- W3173268682 citedByCount "0" @default.
- W3173268682 crossrefType "journal-article" @default.
- W3173268682 hasAuthorship W3173268682A5014898451 @default.
- W3173268682 hasAuthorship W3173268682A5024808796 @default.
- W3173268682 hasAuthorship W3173268682A5033120729 @default.
- W3173268682 hasAuthorship W3173268682A5052312419 @default.
- W3173268682 hasAuthorship W3173268682A5083786375 @default.
- W3173268682 hasAuthorship W3173268682A5089823926 @default.
- W3173268682 hasConcept C126322002 @default.
- W3173268682 hasConcept C134018914 @default.
- W3173268682 hasConcept C151730666 @default.
- W3173268682 hasConcept C177713679 @default.
- W3173268682 hasConcept C2777180221 @default.
- W3173268682 hasConcept C2779134260 @default.
- W3173268682 hasConcept C2779343474 @default.
- W3173268682 hasConcept C2780473172 @default.
- W3173268682 hasConcept C2910068830 @default.
- W3173268682 hasConcept C535046627 @default.
- W3173268682 hasConcept C555293320 @default.
- W3173268682 hasConcept C71924100 @default.
- W3173268682 hasConcept C86803240 @default.
- W3173268682 hasConceptScore W3173268682C126322002 @default.
- W3173268682 hasConceptScore W3173268682C134018914 @default.
- W3173268682 hasConceptScore W3173268682C151730666 @default.
- W3173268682 hasConceptScore W3173268682C177713679 @default.
- W3173268682 hasConceptScore W3173268682C2777180221 @default.
- W3173268682 hasConceptScore W3173268682C2779134260 @default.
- W3173268682 hasConceptScore W3173268682C2779343474 @default.
- W3173268682 hasConceptScore W3173268682C2780473172 @default.
- W3173268682 hasConceptScore W3173268682C2910068830 @default.
- W3173268682 hasConceptScore W3173268682C535046627 @default.
- W3173268682 hasConceptScore W3173268682C555293320 @default.
- W3173268682 hasConceptScore W3173268682C71924100 @default.
- W3173268682 hasConceptScore W3173268682C86803240 @default.
- W3173268682 hasIssue "2" @default.
- W3173268682 hasLocation W31732686821 @default.
- W3173268682 hasOpenAccess W3173268682 @default.
- W3173268682 hasPrimaryLocation W31732686821 @default.
- W3173268682 hasRelatedWork W2018195085 @default.
- W3173268682 hasRelatedWork W2028825353 @default.
- W3173268682 hasRelatedWork W2210990759 @default.
- W3173268682 hasRelatedWork W2263141914 @default.
- W3173268682 hasRelatedWork W2325885830 @default.
- W3173268682 hasRelatedWork W2553015804 @default.
- W3173268682 hasRelatedWork W2903785509 @default.
- W3173268682 hasRelatedWork W3107933435 @default.
- W3173268682 hasRelatedWork W4206946711 @default.
- W3173268682 hasRelatedWork W4362554686 @default.
- W3173268682 hasVolume "8" @default.
- W3173268682 isParatext "false" @default.
- W3173268682 isRetracted "false" @default.
- W3173268682 magId "3173268682" @default.
- W3173268682 workType "article" @default.